Substance use disorder (SUD), also called Drug addiction, is a condition when a person’s use of alcohol and/or drug substances leads to impairment, such as health problems, disability, or problems at work, school, or home. Addiction represents the most severe form of this disorder.
The exact cause of substance use disorder is not known. A person’s genes, the action of the drug, peer pressure, emotional distress, anxiety, depression, and environmental stress can all be factors. Many who develop a substance use problem have depression, attention deficit disorder, post-traumatic stress disorder, or another mental problem. A stressful or chaotic lifestyle and low self-esteem are also common.
There are several stages of drug users that may lead to addiction. Young people seem to move more quickly through the stages than do adults. The stages are experimental use, regular use, Problem or risky use, and addiction. Addiction is the most severe, chronic stage of substance-use disorder, in which there is a substantial loss of self-control, as indicated by compulsive drug taking despite the desire to stop taking the drug. In the DSM-5, the term addiction is synonymous with the classification of severe substance-use disorder.
Get FREE sample copy at:
https://www.delveinsight.com/sample-request/substance-use-disorder-market
The Substance Use Disorder market report also covers emerging drugs, current treatment practices, Substance Use Disorder market share of the individual therapies, current and forecasted Substance Use Disorder Market Size from 2017 to 2030 segmented by seven major markets.
The report provides a detailed current Substance Use Disorder treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.
Substance Use Disorder Market Key Facts
According to the study conducted by Merikangas et al., (2012), titled “Epidemiology of Substance Use Disorders,” the prevalence rates of both alcohol and drug dependence (1.3% and 1.8% respectively) are about one-fourth the magnitude of abuse (5.2% and 7.1%, respectively). Taken together, the lifetime prevalence rates of substance use disorders was 6.5% for alcohol and 8.9% for illicit drugs.
As per the study by Carney et al. (2020), alcohol abuse was the most common lifetime SUD diagnosis (9.3%), followed by alcohol dependence (7.3%) and drug abuse.
According to the American Addiction Centers, in 2017, approximately four percent of the American adolescent population age 12–17 suffered from a substance use disorder. About 1.8% of adolescents had an alcohol use disorder, and about three percent of this population suffered from an illicit drug use disorder.
Key Benefits of Substance Use Disorder Market Report
-
Substance Use Disorder market report provides an in-depth analysis of Substance Use Disorder Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major market i.e. EU5 (Germany, Italy, Spain, France and the UK), Japan, and the United States.
-
The Substance Use Disorder market report will help in developing business strategies by understanding the Substance Use Disorder Market trends & developments, key players and future market competition that will shape and drive the Substance Use Disorder market in the upcoming years.
-
The Substance Use Disorder market report covers Substance Use Disorder current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.
-
The report provides a detailed assessment of the Substance Use Disorder market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population, comparative analysis of pipeline products with detailed clinical profiles, and other factors.
Substance Use Disorder Market
The Substance Use Disorder market outlook section of the report helps to build the detailed comprehension of the historic, current and forecasted Substance Use Disorder market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology.
The report gives a thorough detail of Substance Use Disorder market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Substance Use Disorder Epidemiology
Epidemiological studies of substance use and substance use disorders (SUDs) have provided an abundance of data on the patterns of substance use in nationally representative samples across the world. The striking increase in substance use disorder prevalence rates from ages 13 to 18 highlights adolescence as the key period of development of substance use disorders.
The Substance Use Disorder epidemiology section covers insights about historical and current Substance Use Disorder patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.
It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Substance Use Disorder Drugs Uptake and Key Market Players
The Substance Use Disorder Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Substance Use Disorder market or expected to get launched in the market during the study period. The analysis covers the Substance Use Disorder market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
Some of the key companies in the Substance Use Disorder market include:
MediciNova
Omeros Corp.
KemPharm
InterveXion Therapeutics
Pear Therapeutics
And others.
Substance Use Disorder Therapies Covered:
Ibudilast (MN-166)
OMS405
KP879
IXT-m200
reSET
And many others.
Table of Content
1. Key Insights
2. Executive Summary
3. Substance Use Disorder Competitive Intelligence Analysis
4. Substance Use Disorder Market Overview at a Glance
5. Substance Use Disorder Disease Background and Overview
6. Substance Use Disorder Patient Journey
7. Substance Use Disorder Epidemiology and Patient Population
8. Substance Use Disorder Treatment Algorithm, Current Treatment, and Medical Practices
9. Substance Use Disorder Unmet Needs
10. Key Endpoints of Substance Use Disorder Treatment
11. Substance Use Disorder Marketed Products
12. Substance Use Disorder Emerging Therapies
13. Substance Use Disorder Seven Major Market Analysis
14. Attribute Analysis
15. Substance Use Disorder Market Outlook (7 major markets)
16. Substance Use Disorder Access and Reimbursement Overview
17. KOL Views on the Substance Use Disorder Market.
18. Substance Use Disorder Market Drivers
19. Substance Use Disorder Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
Related Reports
Osteochondromas Market Insight
Osteochondromas Market Insights, Epidemiology, and Market Forecast 2030 report deliver an in-depth understanding of the Osteochondromas, historical and forecasted epidemiology as well as the Osteochondromas market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Tenosynovitis Market Forecast
Tenosynovitis Market Insights, Epidemiology, and Market Forecast 2030 report deliver an in-depth understanding of the Tenosynovitis, historical and forecasted epidemiology as well as the Tenosynovitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd. 2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/